Antonio Sacco
Brescia, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications
The FGF/FGFR/c-Myc axis as a promising therapeutic target in multiple myeloma.
Journal: Journal of experimental & clinical cancer research : CR
Published: August 19, 2024
Editor's Note: Mechanisms of Activity of the TORC1 Inhibitor Everolimus in Waldenstrom Macroglobulinemia.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 16, 2024
Editor's Note: Eph-B2/Ephrin-B2 Interaction Plays a Major Role in the Adhesion and Proliferation of Waldenstrom's Macroglobulinemia.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 16, 2024
Discovery of novel FGF trap small molecules endowed with anti-myeloma activity.
Journal: Pharmacological research
Published: December 20, 2023
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis.
Journal: Blood
Published: June 20, 2023
Liquid Biopsy in Cancer: Focus on Lymphoproliferative Disorders.
Journal: Cancers
Published: September 12, 2022
Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 17, 2022
Last Updated: 09/26/2026